Previous 10 |
Manhattan Scientifics, Inc. ( OTCQB:MHTX ) owns 50+ Million shares of its former wholly-owned subsidiary cancer diagnostic company Imagion Biosystems Ltd. ( AX:IBX ). Volume trading yesterday exceeded 80 million shares @ high of AU $0.010. Manhattan Scientifics acquired and funded 10 years ea...
Manhattan Scientifics Inc. ( MHTX: OTCQ: BB ) , a principal & major shareholder of Imagion Biosystems Ltd. ( IBX.AX ) announces IMAGION’S initiation of manufacturing medical devices and pharma products to be used in first human clinical studies of very early cancer detection as app...
$30 million and 10 years work - Our two nanotechnologies are in the best of hands awaiting commercialization Manhattan Scientifics Inc. ( MHTX: OTCQ: BB ) announces business updates on its two nano technologies. The Nanometals Project , On May 2 nd 2019 MHTX announced that it com...
TV Interview CEO Bob Proulx Explains Cancer Diagnostic https://youtu.be/X4HLKyIl6Zo Manhattan Scientifics (OTC; QB MHTX) announces its former wholly owned sub Imagion Bioscience (ASX:IBX) Receives A$2 million in R&D Tax Incentives from the Australian Government (ATO) Bob Pro...
Breakthrough Device for Detection of Cancer Manhattan Scientifics (OTC: QB MHTX) clarifies that it continues to own 64 million shares of Imagion Biosystems Ltd ( ASX: IBX ). Neither MHTX nor its management have sold any MHTX or IBX shares and have no present intention to do so. T...
Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd ( ASX:IBX ) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging...
Manhattan Scientifics Inc. (MHTX: OTCQ: BB), is pleased to announce that the company has completed an exclusive license and transfer of specialty machines to a large American metals manufacturer who provides specialty metals to the U.S. and global medical industry. The proprietary technology...
News, Short Squeeze, Breakout and More Instantly...
Manhattan Scientifics Inc Company Name:
MHTX Stock Symbol:
OTCMKTS Market:
Manhattan Scientifics Inc Website:
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
Manhattan Scientifics, Inc. (MHTX) is expected to report for Q1 2024
Manhattan Scientifics Inc. ( OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. For further details, please see Imagion Biosystems Press Release About Manhattan Scientifics, Inc....